Description

Cetraxate Hydrochloride is a synthetic amino acid derivative with significant pharmacological activity, primarily functioning as a mucosal protective and anti-ulcer agent. Its value lies in its ability to promote the healing of gastric and duodenal ulcers by enhancing mucosal blood flow and increasing the biosynthesis of prostaglandins. This compound is essential for pharmaceutical R&D and manufacturing, targeting the development of gastrointestinal therapeutics and related clinical research. The product is supplied as Cetraxate, Hydrochloride CAS NO 34675-84-8, meeting the stringent quality requirements of the global pharmaceutical supply chain.

Application

• Pharmaceutical Active Ingredient (API): Primary use in the formulation of anti-ulcer and gastroprotective medications.
• Clinical Research & Development: Serves as a key reference standard and intermediate in preclinical and clinical studies for gastrointestinal disorders.
• Biochemical Research: Used in pharmacological studies to investigate mechanisms of mucosal defense and cytoprotection.
• Generic Drug Manufacturing: Critical for producing generic versions of established gastroprotective drugs containing cetraxate hydrochloride.
• Veterinary Pharmaceuticals: Potential application in developing treatments for gastrointestinal conditions in animals.

Basic Information

Product Name	Cetraxate Hydrochloride
CAS No.	34675-84-8
Molecular Formula	C17H23NO4·HCl
Molecular Weight	341.83 g/mol (Free base: 305.37)
Synonyms	Cetraxate HCl; trans-4-[(3-Methyl-2-butenyl)oxy]phenylacetate Hydrochloride; 4-(3,3-Dimethylallyloxy)phenylacetic Acid 2-(Dimethylamino)ethyl Ester Hydrochloride; KM-1153; N,N-Dimethylaminoethyl p-(3,3-dimethylallyloxy)phenylacetate Hydrochloride; Cetraxatum Hydrochloridum; Cetraxati Hydrochloridum
EINECS	Contact for details

Quality Control

Our Cetraxate Hydrochloride is manufactured under strict quality management systems, with specifications designed to meet the requirements of pharmaceutical ingredient applications. Each batch undergoes comprehensive analytical testing, including identification, purity assay, and impurity profiling via advanced techniques like HPLC. A Certificate of Analysis (COA) is provided with each shipment, detailing all test results against established release criteria. We support compliance with major pharmacopoeial standards and cGMP principles to ensure supply chain integrity for our global partners.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed after each use to prevent degradation from atmospheric moisture. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	98.0% - 102.0% (on anhydrous basis)
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.